PathMDx

The submission displays numerous red flags, including contradictory branding (PathMDx vs SiliconLotus) and absurd, unverifiable claims such as having 'everyone' as an audience and stating 'most people have used my product' for a highly specialized medical AI labeling tool. Given the low quality of the responses, lack of active users, and absence of concrete traction evidence, a 0.5 quality factor penalty was applied across all criteria.